Phathom Pharmaceuticals (PHAT) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.31
-0.97
-0.63
-0.29

Details

Expected EPS
-0.412
Actual EPS
-0.29
Surprise EPS
0.12
Surprise Percent
+29.61%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -0.29 per share for Q1 2026.

0 Comments

Share your thoughts